Subnormal Growth Velocity And Related Factors During GnRH Analog Therapy For Idiopathic Central Precocious Puberty.

about

Subnormal Growth Velocity And Related Factors During GnRH Analog Therapy For Idiopathic Central Precocious Puberty.

Item

http://www.wikidata.org/entity/Q52567658

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Subnormal Growth Velocity And ...... ic Central Precocious Puberty.

@en

Subnormal Growth Velocity And ...... ic Central Precocious Puberty.

@nl

type

Item

label

Subnormal Growth Velocity And ...... ic Central Precocious Puberty.

@en

Subnormal Growth Velocity And ...... ic Central Precocious Puberty.

@nl

prefLabel

Subnormal Growth Velocity And ...... ic Central Precocious Puberty.

@en

Subnormal Growth Velocity And ...... ic Central Precocious Puberty.

@nl

P1476

Subnormal Growth Velocity And ...... ic Central Precocious Puberty.

@en

P2093

Asiye Uğraş Dikmen

http://www.w3.org/2001/XMLSchema#string

Nursel Muratoğlu Şahin

http://www.w3.org/2001/XMLSchema#string

Semra Çetinkaya

http://www.w3.org/2001/XMLSchema#string

Zehra Aycan

http://www.w3.org/2001/XMLSchema#string

P2860

Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: theoretic and practical considerations.

Effects of estrogen on growth plate senescence and epiphyseal fusion.

Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.

Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty.

Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience.

Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.

Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.

Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty.

The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids.

Central precocious puberty in girls: prediction of the aetiology.

P31

scholarly article

P356

10.4274/JCRPE.0023

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29687783

http://www.w3.org/2001/XMLSchema#string

P932

6083469

http://www.w3.org/2001/XMLSchema#string